Mallika Singh

8.5k total citations · 1 hit paper
74 papers, 3.4k citations indexed

About

Mallika Singh is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Mallika Singh has authored 74 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Molecular Biology, 17 papers in Oncology and 16 papers in Cancer Research. Recurrent topics in Mallika Singh's work include PI3K/AKT/mTOR signaling in cancer (12 papers), T-cell and B-cell Immunology (9 papers) and Cancer, Hypoxia, and Metabolism (8 papers). Mallika Singh is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (12 papers), T-cell and B-cell Immunology (9 papers) and Cancer, Hypoxia, and Metabolism (8 papers). Mallika Singh collaborates with scholars based in United States, China and France. Mallika Singh's co-authors include Barbara K. Birshtein, Napoleone Ferrara, Jennifer D. Thompson, Leisa Johnson, Farbod Shojaei, Gregory D. Plowman, Ian Kasman, Fred de Sauvage, Minhong Yan and Scott Stawicki and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Mallika Singh

68 papers receiving 3.3k citations

Hit Papers

Inhibition of Dll4 signalling inhibits tumour growth by d... 2006 2026 2012 2019 2006 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mallika Singh United States 27 2.0k 985 864 605 292 74 3.4k
Lanlan Yu United States 16 2.1k 1.1× 1.1k 1.1× 807 0.9× 690 1.1× 190 0.7× 20 3.3k
Edward R. Kastenhuber United States 20 2.3k 1.1× 1.2k 1.2× 528 0.6× 831 1.4× 107 0.4× 23 3.6k
Kin-Ming Lo United States 27 1.8k 0.9× 1.4k 1.4× 1.1k 1.2× 688 1.1× 789 2.7× 43 3.5k
Olav Engebraaten Norway 29 1.3k 0.7× 925 0.9× 331 0.4× 700 1.2× 402 1.4× 87 2.7k
A. Kate Sasser United States 24 1.8k 0.9× 2.6k 2.6× 1.0k 1.2× 529 0.9× 520 1.8× 54 4.5k
Andrew Sullivan United Kingdom 13 1.2k 0.6× 1.5k 1.5× 511 0.6× 717 1.2× 135 0.5× 23 3.4k
Shetal Patel United States 18 1.4k 0.7× 842 0.9× 596 0.7× 1.2k 2.0× 113 0.4× 40 3.0k
Antonio Daga Italy 35 2.3k 1.1× 1.3k 1.4× 727 0.8× 779 1.3× 79 0.3× 96 4.2k
Maja H. Oktay United States 32 1.5k 0.7× 1.7k 1.7× 893 1.0× 854 1.4× 134 0.5× 84 3.5k
Esther Hulleman Netherlands 28 2.3k 1.1× 1.1k 1.1× 307 0.4× 875 1.4× 138 0.5× 81 3.7k

Countries citing papers authored by Mallika Singh

Since Specialization
Citations

This map shows the geographic impact of Mallika Singh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mallika Singh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mallika Singh more than expected).

Fields of papers citing papers by Mallika Singh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mallika Singh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mallika Singh. The network helps show where Mallika Singh may publish in the future.

Co-authorship network of co-authors of Mallika Singh

This figure shows the co-authorship network connecting the top 25 collaborators of Mallika Singh. A scholar is included among the top collaborators of Mallika Singh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mallika Singh. Mallika Singh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mezzadra, Riccardo, Almudena Chaves Perez, Amanda Kulick, et al.. (2025). A RAS(ON) Multi-Selective Inhibitor Combination Therapy Triggers Long-term Tumor Control through Senescence-Associated Tumor-Immune Equilibrium in Pancreatic Ductal Adenocarcinoma. Cancer Discovery. 15(8). 1717–1739. 2 indexed citations
2.
Schram, Alison M., Abdul Rafeh Naqash, Eric B. Haura, et al.. (2025). The Bi-steric, mTORC1-Selective Inhibitor, RMC-5552, in Advanced Solid Tumors: A Phase 1 Trial. Clinical Cancer Research. 31(23). 4933–4943.
3.
Vostrejs, William P., Rina Sor, Samantha B. Kemp, et al.. (2025). T-cell Dependency of Tumor Regressions and Complete Responses with RAS(ON) Multi-selective Inhibition in Preclinical Models of Pancreatic Ductal Adenocarcinoma. Cancer Discovery. 15(8). 1697–1716. 9 indexed citations
4.
Du, Heng, Heng-Jia Liu, Yu Chi Yang, et al.. (2025). Mitochondrial metabolic rewiring sensitizes mTORC1 inhibitor persister cells to cuproptosis. JCI Insight. 10(22). 1 indexed citations
5.
Singh, Mallika, et al.. (2024). Unlocking Secrets: Bioinformatics' Impact on Forensic Bio-Examinations. International Journal of Network Security & Its Applications. 16(2). 1–15. 1 indexed citations
6.
Singh, Mallika, et al.. (2024). Forensic DNA Profiling: Legal and Ethical Considerations. Journal of Scientific Research and Reports. 30(5). 141–144. 6 indexed citations
7.
Meng, Delong, Xin Zhao, Yu Chi Yang, et al.. (2023). A bi-steric mTORC1-selective inhibitor overcomes drug resistance in breast cancer. Oncogene. 42(28). 2207–2217. 10 indexed citations
8.
Quintana, Elsa, Christopher J. Schulze, Darienne R. Myers, et al.. (2020). Allosteric Inhibition of SHP2 Stimulates Antitumor Immunity by Transforming the Immunosuppressive Environment. Cancer Research. 80(13). 2889–2902. 69 indexed citations
9.
Junttila, Melissa R., Vidusha Devasthali, Jason Chia‐Hsien Cheng, et al.. (2014). Modeling Targeted Inhibition of MEK and PI3 Kinase in Human Pancreatic Cancer. Molecular Cancer Therapeutics. 14(1). 40–47. 43 indexed citations
10.
Bagri, Anil, Leanne Berry, Bert Gunter, et al.. (2010). Effects of Anti-VEGF Treatment Duration on Tumor Growth, Tumor Regrowth, and Treatment Efficacy. Clinical Cancer Research. 16(15). 3887–3900. 110 indexed citations
11.
Brimijoin, Stephen, Yang Gao, Justin J. Anker, et al.. (2008). A Cocaine Hydrolase Engineered from Human Butyrylcholinesterase Selectively Blocks Cocaine Toxicity and Reinstatement of Drug Seeking in Rats. Neuropsychopharmacology. 33(11). 2715–2725. 108 indexed citations
12.
Gao, Yang, David W. LaFleur, Rutul R. Shah, et al.. (2008). An albumin–butyrylcholinesterase for cocaine toxicity and addiction: Catalytic and pharmacokinetic properties. Chemico-Biological Interactions. 175(1-3). 83–87. 42 indexed citations
13.
Brown, Monica, Qinghai Zhao, Kent A. Baker, et al.. (2005). Crystal Structure of BMP-9 and Functional Interactions with Pro-region and Receptors. Journal of Biological Chemistry. 280(26). 25111–25118. 241 indexed citations
14.
Chin, Koei, Mallika Singh, John Hodgson, et al.. (2004). Absence of telomerase and shortened telomeres have minimal effects on skin and pancreatic carcinogenesis elicited by viral oncogenes. Cancer Cell. 6(4). 373–385. 13 indexed citations
15.
Hoffman, Jason A., Enrico Giraudo, Mallika Singh, et al.. (2003). Progressive vascular changes in a transgenic mouse model of squamous cell carcinoma. Cancer Cell. 4(5). 383–391. 182 indexed citations
16.
Singh, Mallika, et al.. (2001). Canonical germinal center B cells may not dominate the memory response to antigenic challenge. International Immunology. 13(5). 643–655. 18 indexed citations
17.
Emelyanov, Alexander, et al.. (2000). BSAP (Pax5)-Importin α1 (Rch1) Interaction Identifies a Nuclear Localization Sequence. Journal of Biological Chemistry. 275(22). 16752–16757. 25 indexed citations
18.
Goldsby, Robert E., Mallika Singh, & Bradley D. Preston. (1998). Mouse DNA polymerase δ gene (Pold1) maps to Chromosome 7. Mammalian Genome. 9(1). 92–93. 4 indexed citations
19.
Birshtein, Barbara K., et al.. (1997). Murine and Human 3′ IgH Regulatory Sequences. Current topics in microbiology and immunology. 224. 73–80. 25 indexed citations
20.
Singh, Mallika & Barbara K. Birshtein. (1993). NF-HB (BSAP) is a Repressor of the Murine Immunoglobulin Heavy-Chain 3'α Enhancer at Early Stages of B-Cell Differentiation. Molecular and Cellular Biology. 13(6). 3611–3622. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026